Catalyst Wire Dossier Catalyst Wire Dossier

Relacorilant

relacorilant · Corcept Therapeutics
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Relacorilant, covering 2018-05-17 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 2]

See pricing